Literature DB >> 17276363

Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients.

Roberto Alvarez-Lafuente1, Marta García-Montojo, Virginia De las Heras, Manuel Bartolomé, Rafael Arroyo.   

Abstract

BACKGROUND: Although the etiology of multiple sclerosis (MS) remains uncertain, clinical, epidemiological, and laboratory findings suggest that environmental factors may be involved in the disease.
OBJECTIVE: This study was undertaken in order to investigate the possible relation of human herpesvirus-6 (HHV-6) in relapsing-remitting MS (RRMS). STUDY
DESIGN: A one-year follow-up study was performed analyzing serum samples of 63 patients with RRMS and 63 healthy blood donors (HBD) by a quantitative real time PCR, to measure HHV-6 prevalence and viral load. Clinical data (starting age and EDSS increase) were collected.
RESULTS: (i) We found 25.4% of RRMS patients with at least one positive serum sample along the one year follow-up. (ii) 19.1% of RRMS samples in relapse had HHV-6 active infection vs. 7.9% of RRMS samples in remission. (iii) We only found variant A. (iv) RRMS patients with HHV-6 active replication initiated the disease 1.9 years earlier, and they had a higher EDSS increase.
CONCLUSIONS: A higher HHV-6A frequency of active infection seems to be related with the exacerbations in a subset of RRMS patients. Regarding the relationship between HHV-6A active infection and the clinical data in RRMS patients, further investigations are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17276363     DOI: 10.1016/S1386-6532(06)70007-5

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  18 in total

Review 1.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

Review 2.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

Review 3.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

4.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

5.  Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Authors:  Guy Mlechkovich; Niza Frenkel
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 6.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

7.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

8.  Abnormal Tr1 differentiation in multiple sclerosis.

Authors:  Anne L Astier; David A Hafler
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

9.  Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Sayed-Hamidreza Mozhgani; Farid Rajabi; Mohsen Qurbani; Yousef Erfani; Somayeh Yaslianifard; Azam Moosavi; Kiomars Pourrostami; Ali Baradaran Bagheri; Alireza Soleimani; Farida Behzadian; Mahshid Safavi; Farhad Rezaei
Journal:  Intervirology       Date:  2021-06-23       Impact factor: 1.763

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.